PURE Bioscience PURE Stock
PURE Bioscience Price Chart
PURE Bioscience PURE Financial and Trading Overview
PURE Bioscience stock price | 0.09 USD |
Previous Close | 0.13 USD |
Open | 0.12 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.08 - 0.12 USD |
52 Week Range | 0.07 - 0.24 USD |
Volume | 397.9K USD |
Avg. Volume | 47.9K USD |
Market Cap | 9.98M USD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PURE Valuation Measures
Enterprise Value | 13.36M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.915994 |
Price/Book (mrq) | 8.147727 |
Enterprise Value/Revenue | 7.92 |
Enterprise Value/EBITDA | -3.614 |
Trading Information
PURE Bioscience Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -55.0000000000000071% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.24 USD |
52 Week Low | 0.07 USD |
50-Day Moving Average | 0.12 USD |
200-Day Moving Average | 0.14 USD |
PURE Share Statistics
Avg. Volume (3 month) | 47.9K USD |
Avg. Daily Volume (10-Days) | 89.73K USD |
Shares Outstanding | 111.36M |
Float | 65.43M |
Short Ratio | 2.56 |
% Held by Insiders | 41.23% |
% Held by Institutions | 0% |
Shares Short | 222.97K |
Short % of Float | 1.85% |
Short % of Shares Outstanding | 1.82% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | July 31, 2022 |
Most Recent Quarter (mrq) | April 30, 2023 |
Next Fiscal Year End | July 31, 2023 |
Profitability
Profit Margin | -246.71% |
Operating Margin (ttm) | -228.21% |
Gross Margin | 45.16% |
EBITDA Margin | -219.14% |
Management Effectiveness
Return on Assets (ttm) | -122.083% |
Return on Equity (ttm) | -294.86% |
Income Statement
Revenue (ttm) | 1.69M USD |
Revenue Per Share (ttm) | 0.02 USD |
Quarterly Revenue Growth (yoy) | -22.30% |
Gross Profit (ttm) | 1M USD |
EBITDA | -3697000 USD |
Net Income Avi to Common (ttm) | -4162000 USD |
Diluted EPS (ttm) | -0.04 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 781K USD |
Total Cash Per Share (mrq) | 0.007 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 2.162 |
Book Value Per Share (mrq) | 0.011 |
Cash Flow Statement
Operating Cash Flow (ttm) | -3137000 USD |
Levered Free Cash Flow (ttm) | -1615875 USD |
Profile of PURE Bioscience
Country | United States |
State | CA |
City | Rancho Cucamonga |
Address | 9669 Hermosa Avenue |
ZIP | 91730 |
Phone | 619 596 8600 |
Website | https://www.purebio.com |
Industry | Household & Personal Products |
Sector(s) | Consumer Defensive |
Full Time Employees | 15 |
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.
Q&A For PURE Bioscience Stock
What is a current PURE stock price?
PURE Bioscience PURE stock price today per share is 0.09 USD.
How to purchase PURE Bioscience stock?
You can buy PURE shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PURE Bioscience?
The stock symbol or ticker of PURE Bioscience is PURE.
Which industry does the PURE Bioscience company belong to?
The PURE Bioscience industry is Household & Personal Products.
How many shares does PURE Bioscience have in circulation?
The max supply of PURE Bioscience shares is 111.86M.
What is PURE Bioscience Price to Earnings Ratio (PE Ratio)?
PURE Bioscience PE Ratio is now.
What was PURE Bioscience earnings per share over the trailing 12 months (TTM)?
PURE Bioscience EPS is -0.02 USD over the trailing 12 months.
Which sector does the PURE Bioscience company belong to?
The PURE Bioscience sector is Consumer Defensive.